Literature DB >> 17899086

Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men.

P Ronco1, H Debiec.   

Abstract

Membranous nephropathy, a disease characterized by an accumulation of immune deposits on the outer aspect of the glomerular basement membrane, is the most common cause of idiopathic nephrotic syndrome in white adults. In the rat model of Heymann nephritis, the target antigen of antibodies is megalin, a multiligand receptor expressed at the podocyte cell surface. This review summarizes key findings provided by this experimental model and by our discovery of neutral endopeptidase being the alloantigen involved in neonatal cases of membranous nephropathy. We discuss the role of alloimmunization as a new mechanism of renal disease and the approach that we use to identify new podocyte antigens. We also summarize current knowledge on the mechanism of proteinuria, with special emphasis on the role of complement. In conclusion, substantial progresses have been made in understanding molecular mechanisms of membranous nephropathy, which should lead to novel therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17899086     DOI: 10.1007/s00281-007-0091-2

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  104 in total

Review 1.  IgG effector mechanisms.

Authors:  M R Clark
Journal:  Chem Immunol       Date:  1997

2.  C5b-8 and C5b-9 modulate the collagen release of human glomerular epithelial cells.

Authors:  I Torbohm; M Schönermark; A M Wingen; B Berger; K Rother; G M Hänsch
Journal:  Kidney Int       Date:  1990-04       Impact factor: 10.612

3.  Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy.

Authors:  Huaiping Yuan; Emiko Takeuchi; Gregory A Taylor; Margaret McLaughlin; Dennis Brown; David J Salant
Journal:  J Am Soc Nephrol       Date:  2002-04       Impact factor: 10.121

4.  Microchimerism of maternal origin persists into adult life.

Authors:  S Maloney; A Smith; D E Furst; D Myerson; K Rupert; P C Evans; J L Nelson
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

5.  Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis.

Authors:  D Kerjaschki; M Exner; R Ullrich; M Susani; L K Curtiss; J L Witztum; M G Farquhar; R A Orlando
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

6.  All four putative ligand-binding domains in megalin contain pathogenic epitopes capable of inducing passive Heymann nephritis.

Authors:  H Yamazaki; R Ullrich; M Exner; A Saito; R A Orlando; D Kerjaschki; M G Farquhar
Journal:  J Am Soc Nephrol       Date:  1998-09       Impact factor: 10.121

7.  Demonstration of C3d deposits in membranous nephropathy.

Authors:  T Doi; K Kanatsu; H Nagai; F Suehiro; T Kuwahara; Y Hamashima
Journal:  Nephron       Date:  1984       Impact factor: 2.847

8.  Factors influencing susceptibility of LEW rats to Heymann nephritis.

Authors:  B Noble; J B Van Liew; G A Andres; J R Brentjens
Journal:  Clin Immunol Immunopathol       Date:  1984-02

9.  IgG subclass deposits in glomeruli of lupus and nonlupus membranous nephropathies.

Authors:  M Haas
Journal:  Am J Kidney Dis       Date:  1994-03       Impact factor: 8.860

10.  Demonstration of a passive Heymann nephritis-like mechanism in a human kidney transplant.

Authors:  M Zanetti; C Mandet; A Duboust; J Bedrossian; J Bariety
Journal:  Clin Nephrol       Date:  1981-05       Impact factor: 0.975

View more
  16 in total

1.  Anti-phospholipase A2 receptor antibody in membranous nephropathy.

Authors:  Weisong Qin; Laurence H Beck; Caihong Zeng; Zhaohong Chen; Shijun Li; Ke Zuo; David J Salant; Zhihong Liu
Journal:  J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 10.121

Review 2.  Anti-neutral endopeptidase, natriuretic peptides disarrangement, and proteinuria onset in membranous nephropathy.

Authors:  Peng Hu; Qiang Xuan; Bo Hu; Ling Lu; Yuan Han Qin
Journal:  Mol Biol Rep       Date:  2012-12-28       Impact factor: 2.316

3.  Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside.

Authors:  Ji Ma; Taiji Matsusaka; Hai-Chun Yang; Jianyong Zhong; Nobuaki Takagi; Agnes B Fogo; Valentina Kon; Iekuni Ichikawa
Journal:  Pediatr Res       Date:  2011-07       Impact factor: 3.756

4.  Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

Authors:  Marco Prunotto; Maria Luisa Carnevali; Giovanni Candiano; Corrado Murtas; Maurizio Bruschi; Emilia Corradini; Antonella Trivelli; Alberto Magnasco; Andrea Petretto; Laura Santucci; Silvia Mattei; Rita Gatti; Francesco Scolari; Peter Kador; Landino Allegri; Gian Marco Ghiggeri
Journal:  J Am Soc Nephrol       Date:  2010-02-11       Impact factor: 10.121

5.  Computational prediction and experimental assessment of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from neutral endopeptidase.

Authors:  Jingbo Zhang; Zhengcai Jia; Zhihua Lin; Jingyi Li; Xiaolan Fu; Yunjian Huang; Jinghong Zhao; Ling Nie; Weiping Hou; Fahuan Yuan; Yuzhang Wu
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

Review 6.  Controversies in the treatment of idiopathic membranous nephropathy.

Authors:  Meryl Waldman; Howard A Austin
Journal:  Nat Rev Nephrol       Date:  2009-07-07       Impact factor: 28.314

7.  Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy.

Authors:  Liyo Kao; Vinson Lam; Meryl Waldman; Richard J Glassock; Quansheng Zhu
Journal:  J Am Soc Nephrol       Date:  2014-09-09       Impact factor: 10.121

8.  Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy.

Authors:  Kelhia Sendeyo; Vincent Audard; Shao-yu Zhang; Qingfeng Fan; Khedidja Bouachi; Mario Ollero; Catherine Rucker-Martin; Elodie Gouadon; Dominique Desvaux; Franck Bridoux; Georges Guellaën; Pierre Ronco; Philippe Lang; Andre Pawlak; Djillali Sahali
Journal:  Kidney Int       Date:  2013-01-09       Impact factor: 10.612

9.  Pathophysiological lessons from rare associations of immunological disorders.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  Pediatr Nephrol       Date:  2008-10-14       Impact factor: 3.714

10.  Novel targets for immunotherapy in glomerulonephritis.

Authors:  Mary H Foster
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.